Welcome to our dedicated page for PARK HA BIOLOGICAL TECHNOLOGY news (Ticker: BYAH), a resource for investors and traders seeking the latest updates and insights on PARK HA BIOLOGICAL TECHNOLOGY stock.
Park Ha Biological Technology Co., Ltd. (Nasdaq: BYAH) is a skincare and cosmetic products company whose activities, based on available information, center on the Park Ha brand in China. The company develops proprietary beauty products under its private skincare label and provides these products through direct sales and franchise alliances promotions. Its brand is described as focusing on solutions for problematic skin, and its operating subsidiaries also offer complimentary after-sales beauty services in physical stores.
This news page highlights company announcements and other coverage related to Park Ha Biological Technology Co., Ltd. One notable development disclosed by the company is the change of its Nasdaq ticker symbol from PHH to BYAH. The company has stated that its ordinary shares will continue to be listed on Nasdaq under the new symbol and that the CUSIP will remain unchanged. In its announcement, the company explained that the symbol change is intended to prevent potential confusion with a delisted company that used the same symbol and to support its long-term brand influence and brand value.
Readers can use this page to follow updates such as corporate communications about trading symbols and other public statements made by Park Ha Biological Technology Co., Ltd. For investors and observers interested in the Park Ha brand’s activities in skincare and cosmetics, this news feed provides a centralized view of disclosed developments and official announcements.
Park Ha Biological Technology (NASDAQ: BYAH) closed a best-efforts follow-on offering of 21,875,000 units at US$0.112 per unit on January 28, 2026, generating approximately US$2.45 million in gross proceeds.
Each unit includes one Class A ordinary share and one warrant exercisable at US$0.112 through the one-year anniversary, with an alternative cashless exercise allowing up to nine shares. Net proceeds are intended to fund expansion of directly operated stores in China.
Park Ha Biological Technology (NASDAQ: BYAH) priced a best-efforts follow-on offering of 21,875,000 units at US$0.112 per unit, with each unit containing one Class A ordinary share and one warrant (warrants exercisable at US$0.112 or via zero-price option up to nine shares). The company expects aggregate gross proceeds of US$2.45 million before placement agent commissions and expenses. Warrants are exercisable from issuance until the one-year anniversary. Closing is expected on or about January 28, 2026, subject to customary conditions. The company intends to use net proceeds to expand directly operated stores in China. D. Boral Capital LLC is sole placement agent and the offering is made under an effective Form F-1 registration statement.
Park Ha Biological Technology (NASDAQ: PHH) will change its Nasdaq ticker symbol to BYAH, effective Tuesday, October 28, 2025. Trading of the Company’s ordinary shares will move from the symbol PHH to BYAH on that date. The Company said the change aims to avoid confusion with a delisted issuer that previously used PHH and to strengthen long-term brand value. No action is required by existing shareholders. The Company will remain listed on Nasdaq and the CUSIP will remain unchanged. The announcement contains standard forward-looking statement disclaimers about risks and uncertainties.